| Efficacy Study of Korean Red Ginseng to Treat Depression (NCT01496248) | Korea University | 2011-08-01 |
| A Study of LY2216684 in Participants With Major Depression Disorder (NCT01370499) | Eli Lilly and Company | 2011-08-01 |
| A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD (NCT01371734) | Pfizer | 2011-08-01 |
| MRI Studies of Emotion in Depression (NCT02429011) | Icahn School of Medicine at Mount Sinai | 2011-07-15 |
| Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder (NCT01395147) | Takeda | 2011-07-01 |
| Wake Therapy in the Treatment of Depression (NCT01431573) | New York State Psychiatric Institute | 2011-07-01 |
| Electronic-Measurement Based Care for Major Depressive Disorder (NCT01583998) | University of Texas Southwestern Medical Center | 2011-06-01 |
| Physical EXercise as an Adjunct Treatment for Depression (NCT02612142) | Université de Reims Champagne-Ardenne | 2011-06-01 |
| The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled Trial (NCT02191124) | Capital Medical University | 2011-06-01 |
| Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder (NCT01380704) | AbbVie | 2011-06-01 |
| Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder (NCT01337609) | Massachusetts General Hospital | 2011-06-01 |
| Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder (NCT01377194) | Forest Laboratories | 2011-06-01 |
| A Study of LY2216684 in Healthy Participants (NCT01380691) | Eli Lilly and Company | 2011-06-01 |
| SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder (NCT01435759) | Shire | 2011-05-31 |
| Use of Multiple Brain Imaging Modalities (PET and MRS) to Identify Metabolic Abnormalities in Major Depression (NCT01465165) | Paul Carlson | 2011-05-15 |
| Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder (NCT01355081) | Takeda | 2011-05-01 |
| The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope (NCT01357967) | Inje University | 2011-05-01 |
| Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression (NCT01234558) | Naurex, Inc, an affiliate of Allergan plc | 2011-05-01 |
| ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD (NCT01381107) | Alkermes, Inc. | 2011-05-01 |
| A Study in Prevention of Re-emergence of Depression Symptoms (NCT01299272) | Eli Lilly and Company | 2011-05-01 |
| A Non Interventional Study to Investigating the Ratio of Mis-diagnosed Bipolar Symptoms in Patient With Major Depressive Disorder (MDD) (NCT01344733) | AstraZeneca | 2011-05-01 |
| Open-label Safety Extension Study of 15 and 20 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults (NCT01323478) | H. Lundbeck A/S | 2011-04-01 |
| Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder (NCT01254305) | Forest Laboratories | 2011-04-01 |
| Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence (NCT01528748) | University of Virginia | 2011-04-01 |
| Dopamine Neurotransmission in Major Depression (NCT01659814) | Mclean Hospital | 2011-03-01 |
| A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor (NCT01185340) | Eli Lilly and Company | 2011-03-01 |
| The Effect of Problem Solving Therapy and Antidepressant Therapy on Cerebral Perfusion and Brain Derived Neurotropic Factor (BDNF) in Depressed Elders (NCT01305889) | University of California, San Francisco | 2011-03-01 |
| Comparison of Tianeptine Versus Escitalopram Patients Major Depressive Disorder (NCT01309776) | Samsung Medical Center | 2011-03-01 |
| Antidepressant Adherence Via AD_IVR (NCT01188135) | Kaiser Permanente | 2011-02-01 |
| A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder. (NCT01288079) | AstraZeneca | 2011-02-01 |
| A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) (NCT01318434) | Euthymics BioScience, Inc. | 2011-02-01 |
| Pioglitazone and Quetiapine XR Pharmacogenetic Study (NCT01342380) | University Hospitals Cleveland Medical Center | 2011-02-01 |
| A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder (NCT01427439) | H. Lundbeck A/S | 2011-02-01 |
| Testing the Effectiveness of a Computer-based Program for Depression (NCT01203683) | University of Texas at Austin | 2011-01-01 |
| Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression (NCT02661789) | Gitte Moos Knudsen | 2011-01-01 |
| Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features (NCT01310140) | Massachusetts General Hospital | 2011-01-01 |
| Type 1 Diabetes and Depression: Role of Brain Glutamate (NCT05355285) | Beth Israel Deaconess Medical Center | 2011-01-01 |
| Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer (NCT01725048) | UNC Lineberger Comprehensive Cancer Center | 2011-01-01 |
| Cellular Aging and Neurobiology of Depression Study (NCT00285935) | University of California, San Francisco | 2010-12-16 |
| Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy (NCT02058693) | Rush University Medical Center | 2010-12-01 |
| Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder (NCT01273376) | Rexahn Pharmaceuticals, Inc. | 2010-12-01 |
| A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors (NCT01263223) | Eli Lilly and Company | 2010-12-01 |
| A Study of LY2216684 and Digoxin in Healthy Subjects (NCT01266590) | Eli Lilly and Company | 2010-12-01 |
| A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel (NCT01263093) | Eli Lilly and Company | 2010-12-01 |
| A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol (NCT01263197) | Eli Lilly and Company | 2010-12-01 |
| A Study of LY2216684 and Theophylline in Healthy Subjects (NCT01263106) | Eli Lilly and Company | 2010-12-01 |
| A Study of LY2940094 in Major Depressive Disorder (NCT01263236) | BlackThorn Therapeutics, Inc. | 2010-12-01 |
| A Study of the Effect of LY2216684 on Lorazepam (NCT01275144) | Eli Lilly and Company | 2010-12-01 |
| A Study of LY2216684 and Warfarin in Healthy Subjects (NCT01263119) | Eli Lilly and Company | 2010-12-01 |
| N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression (NCT01260649) | Massachusetts General Hospital | 2010-11-01 |
| Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support) (NCT01369030) | Pamlab, Inc. | 2010-11-01 |
| Deficits in Emotion Regulation Skills as a Maintaining Factor in Major Depressive Disorder (NCT01330485) | Friedrich-Alexander-Universität Erlangen-Nürnberg | 2010-11-01 |
| A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings (NCT01207271) | University of Pennsylvania | 2010-11-01 |
| Efficacy and Safety of Cranial Electrical Stimulation (CES) for Major Depressive Disorder (MDD) (NCT01325532) | Massachusetts General Hospital | 2010-11-01 |
| A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder (NCT01173601) | Eli Lilly and Company | 2010-11-01 |
| Oral Multiple-dose Study in Patients With Major Depressive Disorder (NCT01924520) | Astellas Pharma Inc | 2010-11-01 |
| A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline (NCT01250873) | Eli Lilly and Company | 2010-11-01 |
| Online Self-help for Depressed Patients Awaiting Psychotherapy (NCT01226238) | University of Luebeck | 2010-10-01 |
| A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together. (NCT01243957) | Eli Lilly and Company | 2010-10-01 |
| Life Goals Behavioral Change to Improve Outcomes for Veterans With Serious Mental Illness (NCT01244854) | VA Office of Research and Development | 2010-10-01 |
| Oxytocin Add-on for Stable Depressed Patients (NCT01211756) | David Feifel | 2010-10-01 |
| Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers (NCT01633437) | CeNeRx BioPharma Inc. | 2010-09-01 |
| Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder (NCT01198795) | Forest Laboratories | 2010-09-01 |
| A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder. (NCT01197508) | AstraZeneca | 2010-09-01 |
| PHARMO Institute Seroquel Safety Study (NCT01342120) | AstraZeneca | 2010-09-01 |
| Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder. (NCT01148979) | Mclean Hospital | 2010-09-01 |
| A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (NCT01180400) | AstraZeneca | 2010-09-01 |
| Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous Administration (NCT01217645) | AstraZeneca | 2010-09-01 |
| Epigenetic Regulation of BDNF in Major Depression (NCT01182103) | Chang Gung Memorial Hospital | 2010-08-01 |
| The Study of Serum Melatonin Rhythm Levels in Patients With Major Depressive Disorder (NCT01357083) | Science & Research Islamic Azad University Branch Khozestan | 2010-08-01 |
| The Effects and Mechanisms of Mindfulness Based Cognitive Therapy (MBCT) on Depressive Symptoms and Depression Relapse (NCT01145872) | University of Denver | 2010-07-01 |
| Cognitive Training for Depression (NCT01936506) | Icahn School of Medicine at Mount Sinai | 2010-07-01 |
| Phenotype Depression Study (NCT01426997) | Emory University | 2010-07-01 |
| A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression (NCT01098240) | Pfizer | 2010-06-14 |
| A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (NCT01152554) | AstraZeneca | 2010-06-01 |
| Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364) (NCT01121484) | Pfizer | 2010-06-01 |
| A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD) (NCT01157078) | AstraZeneca | 2010-06-01 |
| Transcranial Direct Current Stimulation to Treat Major Depressive Disorder (NCT01149889) | University of Sao Paulo | 2010-06-01 |
| Follow-up Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder (NCT01149213) | University of Sao Paulo | 2010-06-01 |
| A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (NCT01153347) | AstraZeneca | 2010-06-01 |
| Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss (NCT01867749) | Brown University | 2010-06-01 |
| The Effect of Patient and Investigator Expectation on the Efficacy of Escitalopram in the Treatment Depression (NCT02480400) | Abarbanel Mental Health Center | 2010-06-01 |
| Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam (NCT00952653) | Pfizer | 2010-06-01 |
| Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) (NCT01156415) | Novartis Pharmaceuticals | 2010-06-01 |
| Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation (NCT01134731) | University of Alabama at Birmingham | 2010-05-01 |
| Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (NCT01110889) | Novartis Pharmaceuticals | 2010-05-01 |
| Pilot Study of Open-label Placebo to Treat Major Depressive Disorder (NCT01103271) | Massachusetts General Hospital | 2010-05-01 |
| Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD) (NCT01110902) | Novartis Pharmaceuticals | 2010-05-01 |
| Deep-brain Magnetic Stimulation (DMS) in the Treatment of Major Depressive Disorder (NCT02184221) | Capital Medical University | 2010-05-01 |
| Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 15 and 20 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults (NCT01140906) | H. Lundbeck A/S | 2010-05-01 |
| Treatment Resistant Geriatric Depression in Primary Care (NCT01392287) | Mclean Hospital | 2010-05-01 |
| 6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder (NCT01145755) | AstraZeneca | 2010-05-01 |
| Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study) (NCT01185977) | University of California, Los Angeles | 2010-04-01 |
| Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder (NCT01109030) | Tehran University of Medical Sciences | 2010-04-01 |
| Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms (NCT01189812) | Columbia Northwest Pharmaceuticals | 2010-03-01 |
| Study Using Pregnenolone to Treat Bipolar Depression (NCT01409096) | University of Texas Southwestern Medical Center | 2010-03-01 |
| A Study in Depression and Associated Painful Physical Symptoms (NCT01070329) | Eli Lilly and Company | 2010-03-01 |
| Meditation to Reduce Caregiver Stress (NCT01537679) | University of California, Los Angeles | 2010-03-01 |
| Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder (NCT01085812) | Forest Laboratories | 2010-03-01 |
| Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (NCT01052077) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2010-03-01 |